Le Lézard
Classified in: Health
Subject: PDT

Mount Prospect, Ill. Gains First Outpatient Vascular Center


MOUNT PROSPECT, Ill., Nov. 30, 2021 /PRNewswire/ -- The first outpatient vascular interventional center in Mount Prospect, Ill., has opened, bringing a new level of convenience, cost savings and state-of-the art care to the northwest Chicagoland area.

Dr. Brian Schirf, a leading Vascular Interventional Radiologist in the greater Chicago area, has opened the Infinity Vascular Institute (IVI) in partnership with Austin, Texas-based Arise Vascular. The opening marks Arise Vascular founders' 14th outpatient facility in the U.S.

The 4,400-square-foot, Medicare-certified Infinity Vascular Institute is located on the ground floor at 1660 Feehanville Drive, Suite 190, in Mount Prospect, Ill.

IVI will be the first office based lab in the vicinity to perform endovascular procedures on an outpatient basis for a wide array of procedures, including: peripheral artery disease (PAD), symptomatic fibroids (uterine fibroid embolization), benign prostatic hypertrophy (prostate artery embolization), vertebral compression fractures (vertebral augmentation/kyphoplasty), cancer treatment (port placement/tumor embolization), varicoceles/pelvic congestion syndrome (embolization/stenting) and end-stage-renal-disease (fistula/graft management).  

"Partnering with Arise Vascular has enabled our center to be operational in a short time period despite pandemic supply chain challenges," said Dr. Schirf. "We look forward to delivering the best care to our patients throughout the region."  

Infinity Vascular Institute brings a team of highly focused experts to each patient visit offering a personalized experience with one-on-one nursing care. When treatments are performed in an office-lab environment, most patients are discharged to the comfort of their own home in just a few hours. Office-based labs often have a lower cost to the patient as well as payers and limit exposure to acutely ill patients.

For consultations and questions, please contact Dr. Schirf by phone (847-916-0606).

About Arise Vascular
Arise Vascular empowers physicians to gain more control over their practice and care of patients. With more than 50 years of experience working in the outpatient sector, its executive team works directly with physicians to develop and manage independent Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs) focused on catheterization. Since 2008, Arise Vascular's team has opened six ambulatory surgery centers and eight office-based catheterization labs - all of which are physician-owned. For more information, visit: www.arisevascular.com.

SOURCE Arise Vascular


These press releases may also interest you

at 12:53
Sports nutrition and lifestyle brand Bucked Up launched its Babe by Bucked Up line last October with a desire to create supplements made by women, for women. With its official launch now six months underway, Babe has become a huge sensation and...

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...



News published on and distributed by: